Corvus Pharmaceuticals
CRVS
CRVS
38 hedge funds and large institutions have $55.6M invested in Corvus Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
38
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$494K | |
| 2 | +$438K | |
| 3 | +$275K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$32K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$24.2K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$248K | |
| 3 | -$132K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$80.5K |
| 5 |
Morgan Stanley
New York
|
-$48.7K |